The aggregation of amyloid-b peptide (Ab) has been linked to the formation of neuritic plaques, which are pathological hallmarks of Alzheimer's disease. We synthesized peptides containing fluorinated amino acids and studied their effect on the Ab aggregation. The peptides were based on the sequence LVFFD, in which valine was substituted by either 4,4,4-trifluorovaline or 4-fluoroproline, or the phenylalanine at position 3 was replaced by 3,4,5-trifluorophenylalanine. Our results demonstrate that fluorination of the hydrophobic residue valine or phenylalanine is effective in preventing the Ab aggregation. This study opens up the possibility of using new sequences based on fluorinated amino acids to inhibit the amyloid-fibril formation.
Introduction
Amyloid b-peptide (Ab) is about 4 kDa and it accumulates extracellularly in the brain as amyloid brils, which form the dense aggregates -neuritic plaques -that pathologically characterize Alzheimer's disease (AD). 1 The aggregation process of Ab is described as a nucleation process, with the formation of unstable intermediates that act as seeds. At least two intermediates have been identied during amyloid bril formation: intermediates that are soluble and of low molecular weight, composed of dimeric or oligomeric peptide molecules, and the protobrils that are short and exible brils. 2 Increasing evidence suggests that soluble Ab oligomers might be critical for the onset of AD. [3] [4] [5] [6] [7] In the view of this hypothesis, a possible strategy to treat the disease is to inhibit the early stages of Ab aggregation. 8 The two hydrophobic cores of Ab, the residues 17-21 and 30-42, have been associated with the peptide aggregation.
9,10 Soto et al. designed a short peptide, based on the 17-21 hydrophobic core of Ab (LVFFA), which binds to the full length Ab and prevents its aggregation.
11 This inhibitor has a similar degree of hydrophobicity to that of the 17-21 core but it has a very low propensity to adopt a b-sheet conformation due to the presence of a proline residue. Valine, which is considered a key residue for the b-sheet formation, was replaced by proline and alanine was substituted by aspartic acid to improve the peptide solubility. [11] [12] [13] The sequence LPFFD, referred to as iAb 5 , binds to Ab and blocks the Ab-Ab molecule interactions, inhibiting the formation of amyloid brils. Certain uorinated compounds have also been proposed as inhibitors of the Ab aggregation. [14] [15] [16] Fluorinated solvents such as hexauoroisopropanol induce an a-helix structure in Ab peptide. A similar effect is observed when Ab interacts with poly(tetrauoroethylene) surfaces or uorinated nanoparticles. [17] [18] [19] Since the hydrogenated analogues of the nanoparticles were not able to prevent the amyloid bril formation, it has been postulated that uorine atoms play an important role in the inhibition of Ab aggregation. We have thus synthesized peptides containing uorinated amino acids and studied their inuence on Ab oligomerization. The uorinated peptides are also based on the hydrophobic central residues of Ab 17-21 (LVFFA) and on the iAb 5 beta-sheet breaker peptide. The aim is to study the impact of uorine atoms on the beta-sheet breaker property of short peptide sequences and to understand the role of uorine atoms on the Ab aggregation. The uorinated sequences were covalently linked to polyethylene glycol (PEG) to increase their solubility (Fig. 1) . We previously showed that coupling iAb 5 to PEG does not compromise its affinity to Ab or the iAb 5 beta-sheet breaker activity.
20 PEG has relatively low toxicity and is known to reduce proteolytic degradation. 21 The use of non-natural residues such as uori-nated amino acids is also described to efficiently improve the stability of peptides or proteins against enzymatic degradation. 22 The conjugates of uorinated peptide-PEG were characterized by matrix-assisted laser desorption/ionization mass spectrometry. The kinetics of Ab aggregation, in the presence of the conjugates, were evaluated by the thioavin T assay and the data were tted using the crystallization-like model recently described by Crespo et al. 23 The ultrastructure characterization of the Ab aggregates was performed by transmission electron microscopy.
Material and methods

Synthesis of conjugates of uorinated peptides and polyethylene glycol
The conjugates were prepared by the solid-phase supported strategy. Fig. 1 . Aer the synthesis, the conjugates were dissolved in distilled water with 1% guanidinium hydrochloride and the pH was adjusted to 7 with 1 M sodium hydroxide. The samples were dialyzed against ultrapure water using a regenerate cellulose membrane (MWCO 1000 Da) for 4 days followed by lyophilization.
Stock solutions of amyloid-b peptide
Ab microliter of the analyte solution was mixed with l mL of an alpha-cyano-4-hydroxycinnamic acid matrix solution consisting of 10 mg of the matrix dissolved in 1 mL of 0.1% TFA in acetonitrile-water (1 : 1, v/v). From the resulting mixture, 1 mL was applied to the sample plate. Samples were air-dried at room temperature (25 C). Each spectrum is a mean of 250 laser shots.
Thioavin T (ThT) binding assay
For kinetic studies, Ab peptide (12.5 mM) was incubated at 37 C in 96 well plates (Nunclon Delta Surface) with the uori-nated peptide-PEG conjugates (250 mM) in the presence of ThT (0.7 mg mL À1 ) in a PBS buffer. The ThT solution was ltered using a 0.2 mm syringe lter before adding to the Ab samples.
The brils conjugated with ThT have the excitation maximum at 450 nm and enhanced emission at 482 nm. 24 The uorescence intensity was measured every 30 minutes during 24 hours using a Biotek Synergy 2 uorescence spectrometer with the excitation lter at 420/50 nm and the emission lter at 485/20 nm. Student's t-test statistical analysis was used to determine statistical signicance between Ab (1-42) incubated alone and Ab incubated with conjugates (n $ 3).
Theoretical crystallization-like model
The crystallization-like model (CLM) is a generic two-parameter model that describes protein aggregation kinetics by a sequence of nucleation and growth steps. The CLM is represented by the following equation, in which a represents the normalized fraction of amyloid protein converted into brils.
and k a and k b are the growth and the nucleation-to-growth rate constants. The two parameters are related to the time required to reach half of the total bril conversion (t 50 ) and to the aggregation rate (v 50 ) given the slope of the a(t) curve at that instant.
Transmission electron microscopy (TEM)
The Ab peptide (100 mM) was incubated at 37 C with each of the uorinated peptide-PEG conjugates (2 mM) in a PBS buffer (10 mM, pH: 7.4), for 48 hours. An aliquot of each sample (5 mL) was placed on carbon-formvar coated 200-400 mesh spacing grids and let to adsorb for ve minutes. The negative staining was performed with a 2% ltered aqueous solution of uranyl acetate for 45 seconds. The grids were visualized using a Jeol JEM 1400 electron microscope at 80 kV. 
Results
Fluorinated peptide-PEG conjugates
The uorinated sequences conjugated to PEG were analysed by MALDI-TOF-MS. The spectrum of LP f FFD-PEG is depicted as representative of the results acquired for the conjugates and shows the typical distribution of the polymer PEG with the characteristic repeat unit of 44.1 AE 0.5 Da, which could be assigned to the ethylene oxide (EO) monomer of the PEG (Fig. 2) Impact of the peptide-PEG conjugates on Ab brillization
The aggregation of Ab incubated at 37 C with LP f FFD-PEG, LVF f FD-PEG and LV f FFD-PEG at a molar ratio of 1 : 20 was evaluated by the ThT binding assay ( Fig. 3 and 4) . At 15 minutes incubation time, the ThT uorescence intensity is low for all samples, which indicates low content of amyloid brils. Aer two hours, a large increase in the uorescence intensity is observed for Ab alone and for the Ab :LP f FFD-PEG samples, reaching the maximum at 4 hour incubation time (the uorescence intensities were normalized to that of Ab incubated with ThT at 37 C for 24 hours). The uorescence of
ThT in the presence of Ab and LVF f FD-PEG showed only a moderated increase (53%) aer 4 hours, whereas that of the sample Ab :LV f FFD-PEG remained low (15%). The conjugates in the absence of Ab do not induce any change in the uorescence signal of ThT. The kinetic data were tted according to the recently proposed CLM model (Fig. 4) . The time at half bril conversion (t 50 ) and the aggregation rate (v 50 ) were obtained by tting a sigmoidal function to each kinetic trace according to the CLM (Table 1) . 23 In the case of sigmoidal-type aggregation kinetics such as those represented in Fig. 4 , v 50 is solely dictated by the growth rate constant k a . The parameter v 50 did not change signicantly in the presence of the conjugates. A marked increase in the value of t 50 is, however, evident for the LVF f FD-PEG and LV f FFD-PEG, which can be explained by the CLM as the result of either nucleation-prevention or solubilitychange effects. The latter hypothesis is discarded by the fact that the maximum uorescence signal did not show signicant variation in the presence of conjugates. Therefore, we ascribe the increased induction times to the inhibition of the nucleation step as a possible consequence of the stabilization of the Ab molecule by the conjugates. The higher value of the induction time t 50 is obtained for the conjugate containing the uo-rinated valine (LV f FFD-PEG), suggesting a stronger inhibitory effect in this case. Inhibitors of the amyloid bril formation may act upon the initial assembly of macromolecules forming the stable nuclei (nucleation step) or block the subsequent addition 
of new growth units (growth step).
23 A third way of action involves the alteration of the thermodynamic solubility of the polypeptide. This alternative is more unlikely to result in vivo since cell and tissue media are in general buffered against nonspecic interactions. Compared to the effect of a well-known and well accepted beta-sheet breaker peptide, iAb 5 (LPFFD), on Ab aggregation, a similar effect was obtained by the LV f FFD-PEG conjugate (3.1 hours) ( Table 1) . At the same molar ratio and with the same Ab batch, the reduction of the aggregation time of Ab is similar for iAb 5 and LV f FFD-PEG. The conjugate containing uorinated phenylalanine (LVF f FD-PEG) induced an inhibitory effect of 1.5 hours and the LP f FFD-PEG did not inhibit the Ab aggregation.
The Ab : conjugate molar ratio of 1 : 5 did not signi-cantly change the aggregation parameters of Ab, which indicates that there is a threshold concentration for the Ab-conjugate interactions.
TEM analysis showed that Ab incubation at 37 C for 48 hours resulted in amyloid-like, unbranched brils (Fig. 5) . Ab also formed brils in the presence of the conjugates (or iAb 5 ), although the samples containing LVF f FD-PEG and LV f FFD-PEG show also small aggregates. This analysis demonstrates that the bioconjugates and the beta-sheet breaker iAb5 are only delaying the Ab brillogenesis.
Discussion
Ab is an amphipathic peptide, which self-associates into oligomers that are toxic to cells. 25 The peptide aggregation eventually leads to the formation of amyloid brils, which are known to bind to Congo red and thioavin T dyes. The oligomerization and aggregation of Ab are difficult to control and although many attempts have been made to nd a way to inhibit these processes, the understanding of how different factors can contribute to their initiation is still puzzling. The study on the self-assembly and structural transformation of other amyloid-bril-forming peptides will provide important insights into the understanding of the bril formation process and to nd ways to prevent it.
26-28
We relied on the knowledge that uorine atoms seem to play a role in the prevention of Ab aggregation and developed peptides with uorinated amino acids to screen for brillization inhibitors. The ThT assay evidenced that two of the uorinated peptides (LVF f FD-PEG and LV f FFD-PEG) are able to delay the aggregation of the Ab . Hydrophobic interactions and H-bonding among side-chain groups are the two major driving forces that control protein aggregation.
29 A large amount of evidence indicates that there are three distinct regions within the Ab sequence that might be involved in its aggregation: the central hydrophobic cluster corresponding to the 17-21 region, the 23-28 residues and the hydrophobic C-terminus. [30] [31] [32] Considering that uorine atoms increase the hydrophobicity of the sequences, it is expected that they would interact with the hydrophobic regions of Ab to be segregated away from the water. This interaction might contribute to the prevention of Ab molecules to interact with each other, thus inhibiting their aggregation. The PEG molecules linked to the uorinated peptides can also contribute to the interactions of the conjugates with Ab . We have previously shown that the pegylation of a beta-sheet breaker peptide did not signi-cantly change its binding to Ab . 20 PEG is described to bind to proteins such as albumin and lysozyme even in solution with an ionic strength similar to the physiological conditions.
33
In the case of the uorinated peptide-PEG conjugates, their effect on Ab cannot be simply explained by PEG and Ab interactions since the three conjugates show different outcomes.
The uorinated amino acids of the conjugates may play an important role in delaying the Ab aggregation by interacting with the hydrophobic residues of the peptide. There is also a geometric preference for the interactions between the C-F bond and the side-chain amides of glutamine (E) 15 and asparagine (N) 27 residues.
34 Therefore, the uorine atoms might be able to interact with the two stretches of Ab hydrophobic residues responsible for their oligomerization (17-21 and 30-42 residues) and/or with residues in their vicinity by exploiting the same interactions as in the Ab assembly. A conformational tightened state is produced by the interplay of ionic and hydrophobic groups of both peptide and the conjugates. Table 1 Time required to reach half of the total fibril conversion (t 50 ) and delay in the aggregation of Ab Ferrão-Gonzales et al. showed that (1-anilino-8-naphthalene sulfonate)-derived molecules inhibit Ab aggregation due to their dual nature provided by hydrophobic regions and charged groups. 35 Vieira et al. demonstrated the effectiveness of different uorinated alcohols in the b-to-a refolding process of Ab .
14
The observed effect was interpreted as a result of alteration of the hydration shell of the peptides and hydrophobic effects of uorine groups. Montserret et al. have shown that although the folding of amphipathic a-helical peptides in hydrophilic SDS micellar solutions is mostly driven by electrostatic interactions, when hydrophobic peptides are considered, SDS-peptide hydrophobic interactions might be sufficiently strong to induce a-helical-rich structures. 36 The effect of uorinated complexes made of polyampholyte and the sodium salt of peruorododecanoic acid on Ab was attributed to the hydrophobic and acidic characters of the peruorododecanoic acid. 18, 19 We propose that LVF f FD-PEG and LV f FFD-PEG have the necessary hydrophobicity and spatial geometry to allow the interaction with Ab . LP f FFD-PEG, with one uorine atom in the proline residue, was not able to prevent Ab-Ab interactions. Proline residues are generally solvent-exposed in proteins and they are considered binding motifs in protein-protein interactions.
37
However it is possible that the presence of the uorine atom in the proline residue of the LP f FFD-PEG prevents the exposure of the conjugate amino acids to Ab. Comparing the LP f FFD-PEG with the non-uorinated analogue, one can assume that the uorine atom increases the steric hindrance of the conjugate reducing the access to the proline residue. On the other hand the hydrophobic interactions between LP f FFD-PEG and Ab are probably not strong enough when compared to the Ab-Ab interactions. Apart from the apparently reduced interactions between Ab and LP f FFD-PEG, the position of uorine atoms at the extremity of the conjugate and the uorination of hydrophobic residues seem to favour the inhibitory effect of the sequences on Ab amyloid bril formation.
Conclusions
The effects of uorinated alcohols, molecules or particles on Ab bril formation are typically very different from those of their hydrogenated analogues. In general, it is possible to modify hydrogenated molecules or particles with uorine atoms in such a way that they would be able to induce an a-helix structure on Ab, a conformation which is less prone to aggregation. However, uorination of molecules does not always lead to the inhibition of amyloid bril formation but it can instead promote it. Therefore, it is important to understand the interactions of uorinated molecules with Ab peptide. We propose the use of beta-sheet breaker peptides as model molecules to study the effect of uorination on the Ab aggregation. Therefore, sequences that play an important role in Ab amyloid bril formation were modied with uorine atoms. Our work shows that uorination of hydrophobic amino acids such as valine or phenylalanine of sequences that interfere with amyloid bril formation induces a signicant delay in the Ab aggregation process. This effect is likely a result of the interaction between the uorinated amino acids and the hydrophobic residues of Ab, which is strong enough to prevent the contact between Ab molecules and thus it prevents the peptide aggregation. The uorination of other amino acids or the modication of the uorinated sequences with hydrophilic residues at different positions will contribute to better understand the interactions between Ab and uorinated peptides.
